{"content":"<li class=\"n-box-item date-title\" data-end=\"1483073999\" data-start=\"1482987600\" data-txt=\"Sunday, December 22, 2019\">Thursday, December 29, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3232839\" data-ts=\"1483051316\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYL\" target=\"_blank\">MYL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232839-mylanplus-2_2-launches-generic-version-of-adhd-drug-concerta\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mylan +2.2% as it launches generic version of ADHD drug Concerta</a></h4><ul>   <li>Mylan (<a href=\"https://seekingalpha.com/symbol/MYL\" title=\"Mylan Inc\">MYL</a> <font color=\"green\">+0.5%</font>) is <font color=\"green\">up 2.2%</font> after hours following news of the launch of a generic version of Janssen's Concerta tablets in the U.S.</li>    <li>The product, Methylphenidate Hydrochloride Extended-Release, is indicated for treating Attention Deficit Hyperactivity Disorder.</li>    <li>The launch strengthens a \"robust portfolio\" of central nervous system medications, CEO Heather Bresch says.</li>    <li>The news is one of a string of new generics Mylan is announcing, including a <a href=\"https://seekingalpha.com/news/3232727-mylan-launches-generic-zovia-u-s\" target=\"_blank\">generic version of Zovia tablets</a> and a generic Cerebyx injection.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232839\" data-linked=\"Mylan +2.2% as it launches generic version of ADHD drug Concerta\" data-tweet=\"$MYL - Mylan +2.2% as it launches generic version of ADHD drug Concerta https://seekingalpha.com/news/3232839-mylanplus-2_2-launches-generic-version-of-adhd-drug-concerta?source=tweet\" data-url=\"https://seekingalpha.com/news/3232839-mylanplus-2_2-launches-generic-version-of-adhd-drug-concerta\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232838\" data-ts=\"1483050994\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232838-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a> <font color='green'>+2.1%</font>. <a href='https://seekingalpha.com/symbol/AG' title='First Majestic Silver Corp.'>AG</a> <font color='green'>+1.2%</font>. <a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a> <font color='green'>+1.2%</font>. <a href='https://seekingalpha.com/symbol/DB' title='Deutsche Bank AG'>DB</a> <font color='green'>+0.9%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/LKSD' title='LSC Communications, Inc.'>LKSD</a> <font color='red'>-2.1%</font>. <a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color='red'>-1.4%</font>. <a href='https://seekingalpha.com/symbol/FIS' title='Fidelity National Information Services, Inc.'>FIS</a> <font color='red'>-1.3%</font>. MFS <font color='red'>-1.1%</font>. BBRY <font color='red'>-0.9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232838\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$MYL $AG $ALNY - After Hours Gainers / Losers https://seekingalpha.com/news/3232838-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3232838-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232836\" data-ts=\"1483050086\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INNL\" target=\"_blank\">INNL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232836-innocoll-gets-refusal-to-file-letter-from-fda-on-xaracollminus-52-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Innocoll gets refusal to file letter from FDA on XARACOLL; -52% after hours</a></h4><ul>\n<li>Preliminary review by the U.S FDA ofÂ Innocoll's application labeled insufficient for substantive evaluation.</li>\n<li>Further characterizes XARACOLL, the company's candidate for postsurgical pain treatment, a drug/device combination requiring submission of additional information.</li>\n<li>Innocoll (NASDAQ:<a href=\"https://seekingalpha.com/symbol/INNL\" title=\"Innocoll\">INNL</a>) intends to request a Type A meeting with the FDA to address the various issues.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3232836\" data-linked=\"Innocoll gets refusal to file letter from FDA on XARACOLL; -52% after hours\" data-tweet=\"$INNL - Innocoll gets refusal to file letter from FDA on XARACOLL; -52% after hours https://seekingalpha.com/news/3232836-innocoll-gets-refusal-to-file-letter-from-fda-on-xaracollminus-52-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3232836-innocoll-gets-refusal-to-file-letter-from-fda-on-xaracollminus-52-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232833\" data-ts=\"1483049614\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VISN\" target=\"_blank\">VISN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232833-visionchinaminus-16_6-shareholders-reject-independent-auditor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VisionChina -16.6%; Shareholders reject independent auditor</a></h4><ul>   <li>Shares of out-of-home ad firm VisionChina Media (NASDAQ:<a href=\"https://seekingalpha.com/symbol/VISN\" title=\"VisionChina Media, Inc.\">VISN</a>) tanked into the close in U.S. trading, <font color=\"red\">down 16.6%</font>, and a reason may come in the company's postmarket release describing its annual general meeting.</li>    <li>Shareholders rejected the appointment of Marcum Bernstein &amp; Pinchuk as the company's independent auditors.</li>    <li>The company says appointing Marcum BP had been recommended by the board but the two were unable to agree on commercial terms. The audit committee will seek to appoint a different auditing firm \"as soon as practicable.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232833\" data-linked=\"VisionChina -16.6%; Shareholders reject independent auditor\" data-tweet=\"$VISN - VisionChina -16.6%; Shareholders reject independent auditor https://seekingalpha.com/news/3232833-visionchinaminus-16_6-shareholders-reject-independent-auditor?source=tweet\" data-url=\"https://seekingalpha.com/news/3232833-visionchinaminus-16_6-shareholders-reject-independent-auditor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232822\" data-ts=\"1483047112\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QHC\" target=\"_blank\">QHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232822-quorum-health-closes-sale-of-georgia-hospital\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quorum Health closes sale of Georgia hospital</a></h4><ul>   <li>Quorum Health (<a href=\"https://seekingalpha.com/symbol/QHC\" title=\"Quorum Health Corporation\">QHC</a> <font color=\"red\">-5.2%</font>) has closed a sale of its hospital in Winder, Ga.</li>    <li>As of the New Year, the Barrow Regional Medical Center will transfer to Northeast Georgia Health System.</li>    <li>The move is the second divestiture for the company in the fourth quarter, and \u201cWe continue to focus on improving our financial and operational performance and are in active discussions on further divestiture opportunities,\" says CEO Thomas Miller.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232822\" data-linked=\"Quorum Health closes sale of Georgia hospital\" data-tweet=\"$QHC - Quorum Health closes sale of Georgia hospital https://seekingalpha.com/news/3232822-quorum-health-closes-sale-of-georgia-hospital?source=tweet\" data-url=\"https://seekingalpha.com/news/3232822-quorum-health-closes-sale-of-georgia-hospital\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232821\" data-ts=\"1483046884\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEVO\" target=\"_blank\">GEVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232821-gevo-sets-1-forminus-20-reverse-split-for-jan-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gevo sets 1-for-20 reverse split for Jan. 5</a></h4><ul>   <li>Gevo (<a href=\"https://seekingalpha.com/symbol/GEVO\" title=\"Gevo, Inc.\">GEVO</a> <font color=\"red\">-6%</font>) is <font color=\"red\">off 3.8%</font> after hours following the detailing of a 1-for-20 reverse stock split set for the close on Jan. 5.</li>    <li>Shares will begin trading on a split-adjusted basis on Friday, Jan. 6. The authorized share count will remain at 250M, and proportional adjustments will be made to all conversion/exercise prices.</li>    <li>Fractional shares will be rounded up.</li>    <li>The move is planned to help the company maintain its Nasdaq listing. Share prices dropped below the $1 mark last December.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232821\" data-linked=\"Gevo sets 1-for-20 reverse split for Jan. 5\" data-tweet=\"$GEVO - Gevo sets 1-for-20 reverse split for Jan. 5 https://seekingalpha.com/news/3232821-gevo-sets-1-forminus-20-reverse-split-for-jan-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3232821-gevo-sets-1-forminus-20-reverse-split-for-jan-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232810\" data-ts=\"1483041605\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232810-technology-top-5-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/XGTI' title='xG Technology, Inc.'>XGTI</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/CBAK-OLD' title='China BAK Battery, Inc.'>CBAK-OLD</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/MBLY' title='Mobileye'>MBLY</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/IVAC' title='Intevac, Inc.'>IVAC</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/SMI' title='Semiconductor Manufacturing International Corporation'>SMI</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FNCX' title='Function&#40;x&#41; Inc.'>OTC:FNCX</a> <font color='red'>-19%</font>. MSDI <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a> <font color='red'>-14%</font>. FH <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/INAP' title='Internap Network Services Corporation'>INAP</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232810\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 pm\" data-tweet=\"$XGTI-OLD $CBAK-OLD $MBLY - Technology - Top 5 Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3232810-technology-top-5-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3232810-technology-top-5-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232793\" data-ts=\"1483036117\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBLY\" target=\"_blank\">MBLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232793-wells-fargo-bullish-on-mobileye-deal-indicators\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo bullish on Mobileye-HERE deal indicators</a></h4><ul>\n<li>Though noting necessity for better understanding of impact, <a href=\"http://www.streetinsider.com/Analyst+Comments/Wells+Fargo+Positive+on+Mobileyes+%28MBLY%29+HERE+Deal%2C+Sees+Other+REM+Deals+Forthcoming/12377400.html\" target=\"_blank\">analyst Richard Kwas</a>Â suggests <a href=\"https://seekingalpha.com/news/3232771-mobileye-partner-location-mapping-technologies\" target=\"_blank\">Mobileye and HERE's partnership</a> on mapping technologies could serve as foundation to drive a future recurring revenue inflow and possibly foreshadow further Road Experience Management [REM] announcements, especially with various Mobileye presentations scheduled for CES next month, to come.</li>\n<li>Maintains Outperform rating on Mobileye (NYSE:<a href=\"https://seekingalpha.com/symbol/MBLY\" title=\"Mobileye\">MBLY</a>) shares, now toÂ <font color=\"green\">8.85% gains</font>Â on the session at $38.12, with a $51-$53 target price range.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3232793\" data-linked=\"Wells Fargo bullish on Mobileye-HERE deal indicators\" data-tweet=\"$MBLY - Wells Fargo bullish on Mobileye-HERE deal indicators https://seekingalpha.com/news/3232793-wells-fargo-bullish-on-mobileye-deal-indicators?source=tweet\" data-url=\"https://seekingalpha.com/news/3232793-wells-fargo-bullish-on-mobileye-deal-indicators\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232790\" data-ts=\"1483034452\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232790-financials-top-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:00 PM</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/PHH\" title=\"PHH Corporation\">PHH</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/ASA\" title=\"ASA Gold&amp;Precious Metals\">ASA</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/FCFP\" title=\"First Community Financial Partners, Inc.\">FCFP</a> <font color=\"green\">+5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232790\" data-linked=\"Financials - Top Gainers / Losers as of 1:00 PM\" data-tweet=\"$PHH $ASA $FCFP - Financials - Top Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3232790-financials-top-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3232790-financials-top-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232785\" data-ts=\"1483033661\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KATE\" target=\"_blank\">KATE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232785-bloomberg-kate-spade-commencing-formal-sale-process-next-month\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Kate Spade commencing formal sale process next month</a></h4><ul>\n<li>\n<a href=\"https://www.bloomberg.com/news/articles/2016-12-29/kate-spade-is-said-to-kick-off-formal-sale-process-next-month\" target=\"_blank\">Citing interest</a> drawn from six or so retailers and activist pressure Kate Spade's under, an official auction process is reportedly slated to begin next month with preparations underway through hired financial advisers.</li>\n<li>Kate Spade (NYSE:<a href=\"https://seekingalpha.com/symbol/KATE\" title=\"Kate Spade &amp; Company\">KATE</a>)Â <font color=\"green\">+3.08%</font>Â [<font color=\"green\">5%+</font>Â intraday from last hour].</li>\n<li>Yesterday: <a href=\"https://seekingalpha.com/news/3232656-kate-spade-plus-15_85-percent-sale-exploration-reported-updated\" target=\"_blank\">Kate Spade +15.85%, sale exploration reported [updated]</a>Â / <a href=\"https://seekingalpha.com/news/3232677-michael-kors-coach-rise-intraday-amid-reports-kate-spade-exploring-sale\" target=\"_blank\">Michael Kors, Coach rise intraday amid reports Kate Spade exploring sale</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3232785\" data-linked=\"Bloomberg: Kate Spade commencing formal sale process next month\" data-tweet=\"$KATE - Bloomberg: Kate Spade commencing formal sale process next month https://seekingalpha.com/news/3232785-bloomberg-kate-spade-commencing-formal-sale-process-next-month?source=tweet\" data-url=\"https://seekingalpha.com/news/3232785-bloomberg-kate-spade-commencing-formal-sale-process-next-month\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232787\" data-ts=\"1483033533\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232787-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/KOOL\" title=\"Cesca Therapeutics Inc\">KOOL</a> <font color=\"green\">+35%</font>. <a href=\"https://seekingalpha.com/symbol/FBIO\" title=\"Fortress Biotech, Inc.\">FBIO</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/CBAK-OLD\" title=\"China BAK Battery, Inc.\">CBAK-OLD</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/NTZ\" title=\"Natuzzi S.p.A.\">NTZ</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/ELGX\" title=\"Endologix Inc\">ELGX</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/RIC\" title=\"Richmont Mines, Inc\">RIC</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/AGI\" title=\"Alamos Gold Inc\">AGI</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/GORO\" title=\"Gold Resource Corporation\">GORO</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/AKG\" title=\"Asanko Gold Inc.\">AKG</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/EXK\" title=\"Endeavour Silver Corp.\">EXK</a> <font color=\"green\">+10%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/CEMP\" title=\"Cempra, Inc.\">CEMP</a> <font color=\"red\">-57%</font>. MSDI <font color=\"red\">-14%</font>. GALE <font color=\"red\">-12%</font>. <a href=\"https://seekingalpha.com/symbol/AHPI\" title=\"Allied Healthcare Products, Inc.\">AHPI</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/FNCX\" title=\"Function(x) Inc.\">OTC:FNCX</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/LIVE\" title=\"Live Ventures\">LIVE</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/CBLI\" title=\"Cleveland BioLabs, Inc.\">CBLI</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/KOSS\" title=\"Koss Corporation\">KOSS</a> <font color=\"red\">-9%</font>. SGY <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/CATB\" title=\"Catabasis Pharmaceuticals\">CATB</a> <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232787\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$THMO $FBIO $CBAK-OLD - Midday Gainers / Losers https://seekingalpha.com/news/3232787-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3232787-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232783\" data-ts=\"1483030803\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232783-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/NTZ\" title=\"Natuzzi S.p.A.\">NTZ</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/PME\" title=\"Pingtan Marine Enterprise Ltd.\">PME</a> <font color=\"green\">+9%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/KOSS\" title=\"Koss Corporation\">KOSS</a> <font color=\"red\">-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232783\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$NTZ $PME $KOSS - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3232783-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3232783-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232782\" data-ts=\"1483030794\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IONS\" target=\"_blank\">IONS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232782-bmo-raises-ionis-target-on-spinraza-bullishness\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BMO raises Ionis target on Spinraza bullishness</a></h4><ul>   <li>With a fresh look at pricing and approval for spinal muscular atrophy drug Spinraza, BMO Capital is raising its price target for Ionis Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/IONS\" title=\"Ionis Pharmaceuticals, Inc.\">IONS</a> <font color=\"red\">-4.2%</font>).</li>    <li>The FDA <a href=\"https://seekingalpha.com/news/3232467-fda-oks-nusinersen-spinal-muscular-atrophy-ionis-pharma-3-percent-hours\" target=\"_blank\">approved</a> the treatment Friday and shares of Ionis and licensing partner Biogen (<a href=\"https://seekingalpha.com/symbol/BIIB\" title=\"Biogen Inc.\">BIIB</a> <font color=\"red\">-0.7%</font>) moved up that day.</li>    <li>BMO has boosted its price target on Ionis to $68 from $61, implying near-38% upside, as it expects broad adoption and some higher-than-expected prices.</li>    <li>\u201cThe gross annual cost of $750,000 for a new patient and $375,000 for maintenance <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/12/8849362/ionis-pharmas-target-lifted-to-68-following-more-favorab\" target=\"_blank\">exceeds our prior assumption</a> of $300,000,\" says analyst Do Kim, who sees peak worldwide sales for the drug of $2.4B.</li>    <li>The firm also sees risk/reward for Ionis' Jan. 5 R&amp;D update as \"skewed to the upside\" considering lower expectations for earlier pipeline drugs.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232782\" data-linked=\"BMO raises Ionis target on Spinraza bullishness\" data-tweet=\"$IONS $IONS $BIIB - BMO raises Ionis target on Spinraza bullishness https://seekingalpha.com/news/3232782-bmo-raises-ionis-target-on-spinraza-bullishness?source=tweet\" data-url=\"https://seekingalpha.com/news/3232782-bmo-raises-ionis-target-on-spinraza-bullishness\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232777\" data-ts=\"1483027205\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232777-healthcare-top-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top Gainers / Losers as of 11:00 am</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/KOOL\" title=\"Cesca Therapeutics Inc\">KOOL</a> <font color=\"green\">+34%</font>. <a href=\"https://seekingalpha.com/symbol/FBIO\" title=\"Fortress Biotech, Inc.\">FBIO</a> <font color=\"green\">+26%</font>. <a href=\"https://seekingalpha.com/symbol/ELGX\" title=\"Endologix Inc\">ELGX</a> <font color=\"green\">+19%</font>. PBMD <font color=\"green\">+13%</font>. SGNL <font color=\"green\">+8%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/CEMP\" title=\"Cempra, Inc.\">CEMP</a> <font color=\"red\">-56%</font>. <a href=\"https://seekingalpha.com/symbol/HIIQ\" title=\"Health Insurance Innovations\">HIIQ</a> <font color=\"red\">-15%</font>. GALE <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/MBRX\" title=\"Moleculin Biotech, Inc.\">MBRX</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/SBBP\" title=\"Strongbridge Biopharma\">SBBP</a> <font color=\"red\">-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232777\" data-linked=\"Healthcare - Top Gainers / Losers as of 11:00 am\" data-tweet=\"$THMO $FBIO $ELGX - Healthcare - Top Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3232777-healthcare-top-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3232777-healthcare-top-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232771\" data-ts=\"1483023738\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBLY\" target=\"_blank\">MBLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232771-mobileye-partner-on-location-and-mapping-technologies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mobileye, HERE partner on location and mapping technologies</a></h4><ul>\n<li>Merging the two parties' proficiencies involving autonomous driving, Mobileye's Roadbook will integrate with HERE HD Live Map, Mobileye will gain access to the HERE Open Location Platform and <a href=\"https://here.com/en\" target=\"_blank\">HERE</a> will utilizeÂ raw sensor and observation data from Mobileye as the companies seek to jointly develop a top crowd-sourced HD mappingÂ offering for automakers.</li>\n<li>Further opportunities for collaboration are noted to be explored.</li>\n<li>Mobileye (NYSE:<a href=\"https://seekingalpha.com/symbol/MBLY\" title=\"Mobileye\">MBLY</a>)Â <font color=\"green\">+6%</font>.</li>\n<li>Earlier this week (December 27): <a href=\"https://seekingalpha.com/news/3232513-interest-mapping-firm\" target=\"_blank\">More interest in mapping firm HERE</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3232771\" data-linked=\"Mobileye, HERE partner on location and mapping technologies\" data-tweet=\"$MBLY - Mobileye, HERE partner on location and mapping technologies https://seekingalpha.com/news/3232771-mobileye-partner-on-location-and-mapping-technologies?source=tweet\" data-url=\"https://seekingalpha.com/news/3232771-mobileye-partner-on-location-and-mapping-technologies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232769\" data-ts=\"1483022802\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELGX\" target=\"_blank\">ELGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232769-endologixplus-2_6-resumes-shipments-of-afx-device-systems\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endologix +2.6% as it resumes shipments of AFX device systems</a></h4><ul>   <li>Endologix (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ELGX\" title=\"Endologix Inc\">ELGX</a>) -- which fell on Tuesday as it <a href=\"https://seekingalpha.com/news/3232547-endologix-minus-21_9-percent-holds-shipments-endovascular-device\" target=\"_blank\">decided to hold shipments</a> on a medical device system -- is <font color=\"green\">up 2.6%</font> today after noting it resumed shipments and procedures on some of the products.</li>    <li>The company had held shipments of its AFX Endovascular AAA System to examine a manufacturing issue with some sizes of the product.</li>    <li>After testing, the company has removed the hold on all sizes of the AFX system and some sizes of the AFX2, clearing them for shipments and use in procedures. The company will continue testing remaining sizes of the AFX2.</li>    <li>It will hold a <a href=\"www.endologix.com\" target=\"_blank\">conference call</a> to discuss the issue Friday at 9 a.m. ET.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232769\" data-linked=\"Endologix +2.6% as it resumes shipments of AFX device systems\" data-tweet=\"$ELGX - Endologix +2.6% as it resumes shipments of AFX device systems https://seekingalpha.com/news/3232769-endologixplus-2_6-resumes-shipments-of-afx-device-systems?source=tweet\" data-url=\"https://seekingalpha.com/news/3232769-endologixplus-2_6-resumes-shipments-of-afx-device-systems\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232767\" data-ts=\"1483021798\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232767-galectin-therapeuticsplus-20-private-placements-set-new-funds\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Galectin Therapeutics +20% as private placements set new funds</a></h4><ul>   <li>Galectin Therapeutics has <font color=\"green\">moved up 20%</font> premarket as it wraps a private placement of stock for $3M in new funding.</li>    <li>An existing investor and a new investor bought more than 2.81M shares of common stock above market, and got warrants for common stock exercisable at $5/share.</li>    <li>The company also closed a sale of series B-3 preferred stock for $1.008M in new proceeds.</li>    <li>The placements will \"provide additional funding for our clinical programs, particularly our NASH-CX clinical trial,\" says CEO and CMO Dr. Peter Traber.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232767\" data-linked=\"Galectin Therapeutics +20% as private placements set new funds\" data-tweet=\"Galectin Therapeutics +20% as private placements set new funds https://seekingalpha.com/news/3232767-galectin-therapeuticsplus-20-private-placements-set-new-funds?source=tweet\" data-url=\"https://seekingalpha.com/news/3232767-galectin-therapeuticsplus-20-private-placements-set-new-funds\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232766\" data-ts=\"1483021579\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMMP\" target=\"_blank\">IMMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232766-prima-biomed-up-26-on-melanoma-treatment-trial-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prima BioMed up 26% on melanoma treatment trial data</a></h4><ul>   <li>Prima BioMed (PBMD) is <font color=\"green\">up 26.1%</font> premarket after news of its first clinical data for a program combining its IMP321 with a PD-1 blocking antibody.</li>    <li>The combination is safe and well tolerated at the first dose level, the company says, and dose escalation can continue as it planned.</li>    <li>The results cane in its TACTI-mel trial. \"Patients with unresectable or metastatic melanoma that had suboptimal or no responses to Keytruda have been receiving IMP321 plus Keytruda to help boost their immune responses and increase the tumour response rate to Keytruda,\" the company says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232766\" data-linked=\"Prima BioMed up 26% on melanoma treatment trial data\" data-tweet=\"$IMMP - Prima BioMed up 26% on melanoma treatment trial data https://seekingalpha.com/news/3232766-prima-biomed-up-26-on-melanoma-treatment-trial-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3232766-prima-biomed-up-26-on-melanoma-treatment-trial-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232765\" data-ts=\"1483021557\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CEMP\" target=\"_blank\">CEMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232765-cempra-falls-48-pre-market-on-fda-response-for-solithromycin\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cempra falls 48% pre-market on FDA response for Solithromycin</a></h4><ul>\n<li>Cempra (<a href=\"https://seekingalpha.com/symbol/CEMP\" title=\"Cempra, Inc.\">CEMP</a>) falls after FDA disapproves Solithromycin NDA in current form.</li>\n<li>The letter states that the risk of hepatotoxicity had not been adequately characterized and the size of the safety database of 920 patients is too small to adequately characterize the nature and frequency of serious hepatic adverse effects.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3232765\" data-linked=\"Cempra falls 48% pre-market on FDA response for Solithromycin\" data-tweet=\"$CEMP - Cempra falls 48% pre-market on FDA response for Solithromycin https://seekingalpha.com/news/3232765-cempra-falls-48-pre-market-on-fda-response-for-solithromycin?source=tweet\" data-url=\"https://seekingalpha.com/news/3232765-cempra-falls-48-pre-market-on-fda-response-for-solithromycin\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>128&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232764\" data-ts=\"1483021339\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHLDQ\" target=\"_blank\">SHLDQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232764-sears-holdings-obtains-secured-standby-letter-of-credit-facilityplus-10-pre-market\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sears Holdings obtains secured standby letter of credit facility, +10% pre-market</a></h4><ul>\n<li>Providing for an initial $200M figure and allowing for expansion, at request of Sears Holdings (SHLD), by an additional $300M.</li>\n<li>The facility, supplied by affiliates of ESL Investments (<a href=\"https://www.bloomberg.com/news/articles/2016-12-29/sears-jumps-after-lining-up-200-million-to-help-stay-afloat\" target=\"_blank\">managed by Sears CEO Edward Lampert</a>) through Citibank as agent,Â enables increased liquidity for Sears to support operations.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3232764\" data-linked=\"Sears Holdings obtains secured standby letter of credit facility, +10% pre-market\" data-tweet=\"$SHLDQ - Sears Holdings obtains secured standby letter of credit facility, +10% pre-market https://seekingalpha.com/news/3232764-sears-holdings-obtains-secured-standby-letter-of-credit-facilityplus-10-pre-market?source=tweet\" data-url=\"https://seekingalpha.com/news/3232764-sears-holdings-obtains-secured-standby-letter-of-credit-facilityplus-10-pre-market\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232763\" data-ts=\"1483020893\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232763-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/FBIO\" title=\"Fortress Biotech, Inc.\">FBIO</a> <font color=\"green\">+40%</font>. <a href=\"https://seekingalpha.com/symbol/PHH\" title=\"PHH Corporation\">PHH</a> <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/ELGX\" title=\"Endologix Inc\">ELGX</a> <font color=\"green\">+10%</font>. SHLD <font color=\"green\">+8%</font>. PBMD <font color=\"green\">+8%</font>.</li> <li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/CEMP\" title=\"Cempra, Inc.\">CEMP</a> <font color=\"red\">-48%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3232763\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$FBIO $PHH $ELGX - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3232763-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3232763-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232758\" data-ts=\"1483019473\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNH\" target=\"_blank\">SNH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232758-senior-housing-properties-trust-initiated-overweight-rating-cantor-fitzgerald\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Senior Housing Properties Trust initiated with Overweight rating at Cantor Fitzgerald</a></h4><ul>\n<li>\n<a href=\"http://www.cnbc.com/2016/12/29/early-movers-s-sny-alr-twtr-myl-aapl-more.html\" target=\"_blank\">Setting $23 target</a>, firm cites robust senior housing market fundamentals and Senior Housing Properties Trust's (NYSE:<a href=\"https://seekingalpha.com/symbol/SNH\" title=\"Senior Housing Properties Trust\">SNH</a>) lead positioning within the sector.</li>\n<li>SharesÂ <font color=\"green\">+0.88%</font>Â pre-market at $18.25.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3232758\" data-linked=\"Senior Housing Properties Trust initiated with Overweight rating at Cantor Fitzgerald\" data-tweet=\"$SNH - Senior Housing Properties Trust initiated with Overweight rating at Cantor Fitzgerald https://seekingalpha.com/news/3232758-senior-housing-properties-trust-initiated-overweight-rating-cantor-fitzgerald?source=tweet\" data-url=\"https://seekingalpha.com/news/3232758-senior-housing-properties-trust-initiated-overweight-rating-cantor-fitzgerald\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232735\" data-ts=\"1482996821\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TOSYY\" target=\"_blank\">TOSYY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232735-toshiba-plunges-again-after-rating-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Toshiba plunges again after rating downgrades</a></h4><ul><li>Shares in Toshiba (<a href='https://seekingalpha.com/symbol/TOSYY' title='Toshiba Corp. ADR'>OTCPK:TOSYY</a>) closed <font color='red'>down 17%</font> overnight, clocking a third day of heavy losses <a href=\"http://www.cnbc.com/2016/12/28/toshiba-plunges-26-after-rating-downgrades.html\" target=\"_blank\">following</a> credit downgrades from both Moody's and S&amp;P Global Ratings.</li><li>The conglomerate formally announced late on Tuesday that cost overruns at its U.S. nuclear business might result in \"several billion dollars\" in goodwill charges.</li><li>Since reports of the writedown, Toshiba shares have <font color='red'>tanked 40%</font>, erasing almost $7B in market value.</li></ul><div class=\"tiny-share-widget\" data-id=\"3232735\" data-linked=\"Toshiba plunges again after rating downgrades\" data-tweet=\"$TOSYY $TOSBF - Toshiba plunges again after rating downgrades https://seekingalpha.com/news/3232735-toshiba-plunges-again-after-rating-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3232735-toshiba-plunges-again-after-rating-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":23,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}